Syngenta Acquires Pasteuria Bioscience
Syngenta is to acquire US-based biotechnology company Pasteuria Bioscience for aggregate payments of $86 million, with additional deferred payments of up to $27 million. Pasteuria Bioscience is backed by LSP BioVentures, Advantage Capital and Gordon River Capital.
20 September 2012•3 mins read
